Coeptis Therapeutics Holdings Inc
COEP13.880USD
+1.330+10.60%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
57.83MMarket Cap
LossP/E TTM
More Details of Coeptis Therapeutics Holdings Inc Company
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Company Info
Ticker SymbolCOEP
Company nameCoeptis Therapeutics Holdings Inc
IPO dateDec 17, 2020
CEO- -
Number of employees5
Security typeOrdinary Share
Fiscal year-endDec 17
Address105 Bradford Road, Suite 420
CityWEXFORD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code15090
Phone17249346467
Websitehttps://coeptistx.com/
Ticker SymbolCOEP
IPO dateDec 17, 2020
CEO- -
Company Executives
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Calise (Chris)
6.49%
Mehalick (David)
2.70%
Leonite Fund I LP
2.13%
Armistice Capital LLC
1.97%
Sheehy (Christine Elise)
1.05%
Other
85.67%
Shareholders
Shareholders
Proportion
Calise (Chris)
6.49%
Mehalick (David)
2.70%
Leonite Fund I LP
2.13%
Armistice Capital LLC
1.97%
Sheehy (Christine Elise)
1.05%
Other
85.67%
Shareholder Types
Shareholders
Proportion
Individual Investor
11.27%
Corporation
2.13%
Hedge Fund
1.97%
Investment Advisor
0.64%
Investment Advisor/Hedge Fund
0.42%
Other
83.58%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
42
850.21K
24.20%
+80.97K
2025Q1
44
802.79K
23.54%
+88.77K
2024Q4
46
470.87K
21.82%
-146.34K
2024Q3
60
665.36K
32.36%
-151.44K
2024Q2
63
660.64K
38.75%
-415.23K
2024Q1
86
813.98K
47.41%
-385.62K
2023Q4
86
964.24K
63.23%
-125.48K
2023Q3
87
697.73K
55.24%
-487.79K
2023Q2
87
705.35K
60.53%
-350.78K
2023Q1
84
551.37K
55.07%
-536.93K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Calise (Chris)
359.79K
10.24%
+47.11K
+15.07%
Jun 24, 2025
Mehalick (David)
130.07K
3.7%
--
--
Jun 24, 2025
Leonite Fund I LP
102.50K
2.92%
-10.00K
-8.89%
Jan 05, 2024
Armistice Capital LLC
94.77K
2.7%
+94.77K
--
Sep 30, 2024
Sheehy (Christine Elise)
50.53K
1.44%
--
--
Jun 24, 2025
Yerace (Daniel Alexander)
50.53K
1.44%
--
--
Jun 24, 2025
The Vanguard Group, Inc.
24.44K
0.7%
+24.44K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
19.97K
0.57%
+19.97K
--
Mar 31, 2025
Salkind (Gene)
4.21K
0.12%
--
--
Jun 24, 2025
Sea Otter Advisors LLC
2.25K
0.06%
--
--
Jun 30, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Date
Type
Ratio
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
Dec 27, 2024
Merger
20→1
